Research Focus

Directed by Dr. Zelia Correa, the Ocular Oncology Laboratory focuses on the identification of genetic, epigenetic and genomic abnormalities that lead to poor patient outcome in uveal melanoma, retinoblastoma and other eye cancers, with the goal of developing more accurate prognostic biomarkers and targeted molecular therapies that will lead to improved survival.

The population of South Florida lead our team to investigate the impact of genetic ancestry in outcome of patients with uveal melanoma. Dr. Correa's clinical and research background provides a unique opportunity to fast-track bench research into clinical trials thus improving patient care.